Drug-Drug Cocrystallization Simultaneously Improves Pharmaceutical Properties of Genistein and Ligustrazine

Xuejiao Li, Xinna Liu, Jianmin Song, Chenguang Wang, Jinhui Li, Lianchao Liu, Xin He, Xinghua Zhao, Changquan Calvin Sun

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

The oral delivery of genistein (GEN) is hindered by its low bioavailability. The delivery of tetramethylpyrazine (TMP or ligustrazine) is faced with physical instability challenges due to its high sublimation tendency. We tackled respective challenges of the two drugs by forming a cocrystal. The GEN-TMP cocrystal exhibits a significantly reduced sublimation tendency than TMP and a significant enhancement in both the in vitro release rate and bioavailability in rats than GEN. Thus, cocrystallization simultaneously improves pharmaceutical properties of both parent drugs.

Original languageEnglish (US)
Pages (from-to)3461-3468
Number of pages8
JournalCrystal Growth and Design
Volume21
Issue number6
DOIs
StatePublished - Jun 2 2021

Bibliographical note

Funding Information:
This work was supported by grants from the National Natural Science Foundation of China (Nos. 31872508 and 32002326) and Key Research grants of Hebei (19227505D). We acknowledge the Minnesota Supercomputing Institute at the University of Minnesota for providing resources that contributed to the research results reported within this manuscript. URL: http://www.msi.umn.edu

Publisher Copyright:
© 2021 American Chemical Society

Fingerprint

Dive into the research topics of 'Drug-Drug Cocrystallization Simultaneously Improves Pharmaceutical Properties of Genistein and Ligustrazine'. Together they form a unique fingerprint.

Cite this